A promising molecule, called BT13, has offered hope for a new treatment that could stop or slow Parkinson’s, something no treatment can currently do.
Researchers from the University of Helsinki have found that molecule BT13 has the potential to both boost levels of dopamine, the chemical that is lost in Parkinson’s, as well as protecting the dopamine-producing brain cells from dying.
The results from the study, co-funded by Parkinson’s UK, showed an increase in dopamine levels in the brains of mice following treatment with the molecule. BT13 also activated a specific receptor in the mouse brains to protect the cells.
These findings suggest that BT13 could have the potential to lead to a new drug treatment that can slow, stop or even reverse the loss of brain cells in Parkinson’s.
Why is dopamine important?
Typically, by the time people are diagnosed with Parkinson’s, they have already lost 70-80 per cent of their dopamine-producing cells. These are involved in coordinating movement.
Current treatments mask the symptoms, but there is nothing that can slow down its progression or prevent more brain cells from being lost. As dopamine levels continue to fall, symptoms get worse and new symptoms can appear.
The role of BT13
Researchers are now working on improving the properties of BT13 to make it more effective as a potential treatment. If successful, this could benefit the 145,000 people living with Parkinson’s in the UK.
The study builds on previous research on another molecule that targets the same receptors in the brain, glial cell line-derived neurotrophic factor (GDNF), an experimental treatment for Parkinson’s which was the subject of a major clinical trial funded by Parkinson’s UK. While the results were not clear cut, GDNF has shown promise to restore damaged cells in Parkinson’s.
The GDNF protein requires complex surgery to deliver the treatment to the brain because it’s a large molecule. However BT13, a smaller molecule, could be more easily administered as a treatment if shown to be beneficial in further clinical trials.
“The molecule holds great promise”
Professor David Dexter, Deputy Director of Research at Parkinson’s UK, said: “People with Parkinson’s desperately need a new treatment that can stop the condition in its tracks, instead of just masking the symptoms.
“One of the biggest challenges for Parkinson’s research is how to get drugs past the blood-brain barrier, so the exciting discovery of BT13 has opened up a new avenue for research to explore.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
Parkinson’s
- Cecil Parkinson's tragic children - disabled baby he rejected and daughter who killed herself
The Love Child & the Secretary, the Mirror takes a look at the lives of Cecil Parkinson's tragic children - including the baby he opted never to meet ...
- 4 friends with Parkinson's disease cycling across the country to raise money for research
CHICAGO (CBS) --Four friends will set off on a journey of a lifetime on Wednesday, cycling across America while raising money for two Parkinson's disease foundations. The Chicago-area organizer is ...
- Study links agricultural pesticide exposure to increased genetic variants in Parkinson’s disease
Recent research has highlighted the role of autophagic function in PD etiology, with mutations in the glucosylceramidase beta (GBA1) gene increasing the likelihood of developing PD. In the present ...
- Living your best life after a Parkinson’s diagnosis
Parkinson’s disease is a neurodegenerative disorder that progressively affects movement, leading to significant physical and neurological challenges. While symptoms and disease progression are unique ...
- Pedaling for Parkinson’s
SALT LAKE CITY, Utah (Ivanhoe Newswire) – Nearly one million people in the U.S. are living with Parkinson’s disease. There is no cure and symptoms only get worse. But a new program – backed by ...
Go deeper with Google Headlines on:
Parkinson’s
[google_news title=”” keyword=”Parkinson’s” num_posts=”5″ blurb_length=”0″ show_thumb=”left”]
Go deeper with Bing News on:
BT13
- Feed has no items.
Go deeper with Google Headlines on:
BT13
[google_news title=”” keyword=”BT13″ num_posts=”5″ blurb_length=”0″ show_thumb=”left”]